Bank of America
RGC icon

Bank of America’s Regencell Bioscience RGC Stock Holding History

Bank of America’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$437K Buy
17,172
+17,143
+59,114% +$485K ﹤0.01% 4970
2025
Q4 		$609 Buy
29
+14
+93% +$228 ﹤0.01% 6537
2025
Q3 		$232 Sell
15
-85
-85% -$1.22K ﹤0.01% 7700
2025
Q2 		$1.7K Buy
+100
New +$1.22K ﹤0.01% 7456

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America's RGC Position: Q1 2026 in Review

Bank of America increased its Regencell Bioscience (RGC) stake by 59,114% in Q1 2026, buying an estimated $485K and bringing the position to 17,172 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #4970.

Bank of America first reported a position in RGC in Q2 2025 and has held it in 4 quarters since. 31 funds tracked by Wall St. Rank hold RGC as of Q1 2026.

  • Bank of America held 17,172 shares of Regencell Bioscience worth $437K as of Q1 2026.
  • Bank of America bought 17,143 Regencell Bioscience shares in Q1 2026, an estimated $485K.
  • Regencell Bioscience made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4970 holding.
  • Bank of America first reported a position in Regencell Bioscience in Q2 2025 and has held it in 4 quarters since.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.